MediFind
Condition

Fanconi Anemia

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 36
  • Start Date: June 9, 2020
A Phase II Study of Olaparib in Patients With Advanced Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 28
  • Start Date: August 22, 2019
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant (ASCENT)
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 48
  • Start Date: November 13, 2018
T Cell Receptor Alpha/Beta T Cell Depleted (α/β TCD) Hematopoietic Cell Transplantation in Patients With Fanconi Anemia (FA)
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 25
  • Start Date: November 2, 2018
Eltrombopag for Patients With Fanconi Anemia
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 55
  • Start Date: May 8, 2018
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 24
  • Start Date: March 29, 2018
Pilot Study of Metformin for Patients With Fanconi Anemia
Clinical Trial
Genetic
  • Status: Recruiting
  • Study Type: Genetic
  • Participants: 10
  • Start Date: December 1, 2017
Gene Transfer for Fanconi Anemia Using a Self-inactivating Lentiviral Vector